Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis

• Verfasst von: Kremer, Michael [VerfasserIn]
• Verfasst von: Thomas, Emmanuel [VerfasserIn]
• Verfasst von: Milton, Richard J. [VerfasserIn]
• Verfasst von: Perry, Ashley W. [VerfasserIn]
• Verfasst von: van Rooijen, Nico [VerfasserIn]
• Verfasst von: Wheeler, Michael D. [VerfasserIn]
• Verfasst von: Zacks, Steven [VerfasserIn]
• Verfasst von: Fried, Michael [VerfasserIn]
• Verfasst von: Rippe, Richard A. [VerfasserIn]
• Verfasst von: Hines, Ian N. [VerfasserIn]
• Titel: Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis
• Verf.angabe: Michael Kremer, Emmanuel Thomas, Richard J. Milton, Ashley W. Perry, Nico van Rooijen, Michael D. Wheeler, Steven Zacks, Michael Fried, Richard A. Rippe, and Ian N. Hines
• E-Jahr: 2010
• Jahr: January 2010
• Umfang: 12 S.
• Fussnoten: Zuerst veröffentlicht: 23 December 2009 ; Gesehen am 01.03.2023
• Titel Quelle: Enthalten in: Hepatology
• Ort Quelle: [Alphen aan den Rijn] : Wolters Kluwer Health, 1981
• Jahr Quelle: 2010
• Band/Heft Quelle: 51(2010), 1, Seite 130-141
• ISSN Quelle: 1527-3350
• DOI: doi:10.1002/hep.23292
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1837827451

Abstract

Hepatosteatosis is associated with increased expression of tumor necrosis factor alpha (TNF-α) and interleukin (IL)-12, major T helper (Th) 1 cytokines, and reduced hepatic natural killer T (NKT) cell numbers. The relationship between lipid accumulation, cytokine expression, and hepatic NKT cells is not known. This study was conducted to assess the role of IL-12 in the development of hepatic steatosis and its potential impact on liver NKT cells. Male C57Bl/6 wildtype (WT) and IL-12-deficient (IL-12−/−) mice were fed a choline-deficient diet (CDD) for 0, 10, or 20 weeks. CDD led to marked hepatosteatosis, reduced hepatic but not splenic NKT cell numbers and function, and increased hepatic expression of the Th1-type cytokines IL-12, interferon gamma (IFN-γ), and TNF-α in WT mice. The absence of IL-12 resulted in similar CDD-induced hepatosteatosis, but preserved hepatic NKT cells and significantly reduced hepatic IFN-γ and TNF-α expression. Treatment of CDD-fed mice with lipopolysaccharide led to a significant increase in hepatic IL-12 expression, and Kupffer cell (KC) depletion reduced liver IL-12 expression and restored NKT cells in CDD-induced fatty liver. Interestingly, KCs from CDD-fed mice failed to produce increased quantities of IL-12 upon activation in vitro when compared to similarly treated KCs from control fed mice, suggesting that secondary factors in vivo promote heightened IL-12 production. Finally, human livers with severe steatosis showed a substantial decrease in NKT cells. Conclusion: Hepatosteatosis reduces the numbers of hepatic NKT cells in a KC-and IL-12-dependent manner. Our results suggest a pivotal and multifunctional role of KC-derived IL-12 in the altered immune response in steatotic liver, a process that is likely active within human nonalcoholic fatty liver disease. (HEPATOLOGY 2010;51:130-141.)